156 related articles for article (PubMed ID: 3892307)
1. Overproduction of p53 antigen makes established cells highly tumorigenic.
Eliyahu D; Michalovitz D; Oren M
Nature; 1985 Jul 11-17; 316(6024):158-60. PubMed ID: 3892307
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion.
Tuck SP; Crawford L
Oncogene Res; 1989; 4(2):81-96. PubMed ID: 2654816
[TBL] [Abstract][Full Text] [Related]
3. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
Rovinski B; Benchimol S
Oncogene; 1988 May; 2(5):445-52. PubMed ID: 3287278
[TBL] [Abstract][Full Text] [Related]
4. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.
Eliyahu D; Raz A; Gruss P; Givol D; Oren M
Nature; 1984 Dec 13-19; 312(5995):646-9. PubMed ID: 6095116
[TBL] [Abstract][Full Text] [Related]
5. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.
Parada LF; Land H; Weinberg RA; Wolf D; Rotter V
Nature; 1984 Dec 13-19; 312(5995):649-51. PubMed ID: 6390217
[TBL] [Abstract][Full Text] [Related]
6. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
7. Neoplastic transformation of rat 3Y1 cells by a transcriptionally activated human c-myc gene and stabilization of p53 cellular tumor antigen in the transformed cells.
Shiroki K; Segawa K; Koita Y; Shibuya M
Mol Cell Biol; 1986 Dec; 6(12):4379-86. PubMed ID: 3025654
[TBL] [Abstract][Full Text] [Related]
8. Meth A fibrosarcoma cells express two transforming mutant p53 species.
Eliyahu D; Goldfinger N; Pinhasi-Kimhi O; Shaulsky G; Skurnik Y; Arai N; Rotter V; Oren M
Oncogene; 1988 Sep; 3(3):313-21. PubMed ID: 3060794
[TBL] [Abstract][Full Text] [Related]
9. The cellular oncogene p53 can be activated by mutagenesis.
Jenkins JR; Rudge K; Chumakov P; Currie GA
Nature; 1985 Oct 31-Nov 6; 317(6040):816-8. PubMed ID: 3903515
[TBL] [Abstract][Full Text] [Related]
10. p53-plus-ras-transformed rat embryo fibroblasts express tumor-specific transplantation antigen activity which is shared by independently transformed cells.
Frey AB; Levine AJ
J Virol; 1989 Dec; 63(12):5440-4. PubMed ID: 2531235
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
Matlashewski G; Lamb P; Pim D; Peacock J; Crawford L; Benchimol S
EMBO J; 1984 Dec; 3(13):3257-62. PubMed ID: 6396087
[TBL] [Abstract][Full Text] [Related]
12. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
13. Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines.
Hinds PW; Finlay CA; Frey AB; Levine AJ
Mol Cell Biol; 1987 Aug; 7(8):2863-9. PubMed ID: 3313006
[TBL] [Abstract][Full Text] [Related]
14. The p53 cellular tumor antigen: gene structure, expression and protein properties.
Oren M
Biochim Biophys Acta; 1985 Nov; 823(1):67-78. PubMed ID: 3902087
[No Abstract] [Full Text] [Related]
15. Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.
Meade-Tollin LC; Boukamp P; Fusenig NE; Bowen CP; Tsang TC; Bowden GT
Br J Cancer; 1998 Mar; 77(5):724-30. PubMed ID: 9514050
[TBL] [Abstract][Full Text] [Related]
16. Transformation-related cellular protein p53: increased level in untransformed rat cells following treatment with the tumorpromoter, tetradecanoylphorbol-acetate.
Hebel M; Brandner G; Hochkeppel HK; Braun DG
Z Naturforsch C J Biosci; 1986; 41(1-2):94-9. PubMed ID: 2939645
[TBL] [Abstract][Full Text] [Related]
17. Cell immortalization and transformation by the p53 gene.
Lane DP
Nature; 1984 Dec 13-19; 312(5995):596-7. PubMed ID: 6095111
[No Abstract] [Full Text] [Related]
18. Cloning and sequencing of CATR1.3, a human gene associated with tumorigenic conversion.
Li D; Noyes I; Shuler C; Milo GE
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6409-13. PubMed ID: 7604004
[TBL] [Abstract][Full Text] [Related]
19. The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.
Jones SN; Sands AT; Hancock AR; Vogel H; Donehower LA; Linke SP; Wahl GM; Bradley A
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14106-11. PubMed ID: 8943068
[TBL] [Abstract][Full Text] [Related]
20. The use of monoclonal antibodies for selection of a low-abundance mRNA: p53.
Benchimol S; Matlashewski G; Crawford L
Biochem Soc Trans; 1984 Aug; 12(4):708-11. PubMed ID: 6092166
[No Abstract] [Full Text] [Related]
[Next] [New Search]
